Jack Cunningham

Jack is an associate in the Corporate technology and Life sciences team in London. He specialises in advising companies and investors in the technology and life science sectors on venture capital investments, M&A transactions and general corporate matters.

CV

Since 2024 Associate, Taylor Wessing

2022 - 2024 Trainee Solicitor, Taylor Wessing

Carrière

Since 2024 Associate, Taylor Wessing

2022 - 2024 Trainee Solicitor, Taylor Wessing

Formation

2024 Admitted as a lawyer

2022 Master of Laws, BPP Law School (London

2022 Legal Practical Course, BPP Law School (London)

Actualités et publications récentes

View Jack's insights

Cliquer ici pour en savoir plus

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising BeZero Carbon on US$32 million Series C funding

16 janvier 2025

par plusieurs auteurs

Expertise

Services et Groupes

CV

Carrière

Formation

Actualités et publications récentes

Advising BeZero Carbon on US$32 million Series C funding

Jack Cunningham

Expertise

Services et Groupes

CV

Carrière

Formation

Actualités et publications récentes

Advising BeZero Carbon on US$32 million Series C funding

Related news & insights

Advising Toho Global on its acquisition of Anime Limited

EU Inc.: Founders and companies with expansion plans must now think strategically

Advising Nuclera on its extended Series C funding to US$87 million

Taylor Wessing renforce son positionnement international avec la création d'un département China Desk et la nomination de Laurence Ren en qualité d’associée

Law firm Taylor Wessing Czech Republic legal advisor on Keystone office building acquisiton in Karlín

Advising on multiple high-profile transactions during 2025 highlighting strategic success

Taylor Wessing advises Voltatron AG on the acquisition of Komitec Electronics GmbH

Advising on the sale of DreamTec Systems to FleetGO

Advising Azenta on its US$63 million sale of B Medical Systems

Advising Secret Escapes on the sale of Slevomat

Autres avocats qui pourraient vous intéresser

Rendez-vous à